Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study

Authors: Rose Galvin, Doireann Joyce, Eithne Downey, Fiona Boland, Tom Fahey, Arnold K Hill

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

The number of primary care referrals of women with breast symptoms to symptomatic breast units (SBUs) has increased exponentially in the past decade in Ireland. The aim of this study is to develop and validate a clinical prediction rule (CPR) to identify women with breast cancer so that a more evidence based approach to referral from primary care to these SBUs can be developed.

Methods

We analysed routine data from a prospective cohort of consecutive women reviewed at a SBU with breast symptoms. The dataset was split into a derivation and validation cohort. Regression analysis was used to derive a CPR from the patient’s history and clinical findings. Validation of the CPR consisted of estimating the number of breast cancers predicted to occur compared with the actual number of observed breast cancers across deciles of risk.

Results

A total of 6,590 patients were included in the derivation study and 4.9% were diagnosed with breast cancer. Independent clinical predictors for breast cancer were: increasing age by year (adjusted odds ratio 1.08, 95% CI 1.07-1.09); presence of a lump (5.63, 95% CI 4.2-7.56); nipple change (2.77, 95% CI 1.68-4.58) and nipple discharge (2.09, 95% CI 1.1-3.97). Validation of the rule (n = 911) demonstrated that the probability of breast cancer was higher with an increasing number of these independent variables. The Hosmer-Lemeshow goodness of fit showed no overall significant difference between the expected and the observed numbers of breast cancer (χ2 HL: 6.74, p-value: 0.56).

Conclusions

This study derived and validated a CPR for breast cancer in women attending an Irish national SBU. We found that increasing age, presence of a lump, nipple discharge and nipple change are all associated with increased risk of breast cancer. Further validation of the rule is necessary as well as an assessment of its impact on referral practice.
Appendix
Available only for authorised users
Literature
1.
go back to reference National Cancer Registry Ireland: Breast Cancer Incidence, Mortality, Treatment and Survival in Ireland: 1994–2009. 2012, Cork National Cancer Registry Ireland: Breast Cancer Incidence, Mortality, Treatment and Survival in Ireland: 1994–2009. 2012, Cork
2.
go back to reference Mutrie N, Campbell AM, Whyte F, Mcconnachie A, Emslie C, Lee L, Kearney N, Walker A, Ritchie D: Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial. BMJ. 2007, 334: 517-10.1136/bmj.39094.648553.AE.CrossRefPubMedPubMedCentral Mutrie N, Campbell AM, Whyte F, Mcconnachie A, Emslie C, Lee L, Kearney N, Walker A, Ritchie D: Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial. BMJ. 2007, 334: 517-10.1136/bmj.39094.648553.AE.CrossRefPubMedPubMedCentral
3.
go back to reference Burckhardt CS, Jones KD: Effects of chronic widespread pain on the health status and quality of life of women after breast cancer surgery. Health Qual Life Outcomes. 2005, 3: 30-10.1186/1477-7525-3-30.CrossRefPubMedPubMedCentral Burckhardt CS, Jones KD: Effects of chronic widespread pain on the health status and quality of life of women after breast cancer surgery. Health Qual Life Outcomes. 2005, 3: 30-10.1186/1477-7525-3-30.CrossRefPubMedPubMedCentral
4.
go back to reference Department of Health and Children: National Quality Assurance Standards for Symptomatic Breast Disease Services - Developing Quality Care for Breast Services in Ireland. 2007, Dublin Department of Health and Children: National Quality Assurance Standards for Symptomatic Breast Disease Services - Developing Quality Care for Breast Services in Ireland. 2007, Dublin
5.
go back to reference O’Rourke N: Review of Referral Patterns and Triage Processes in Symptomatic Breast Units. A hospital perspective. 2012, Dublin: National Cancer Control Programme O’Rourke N: Review of Referral Patterns and Triage Processes in Symptomatic Breast Units. A hospital perspective. 2012, Dublin: National Cancer Control Programme
6.
go back to reference McGinn T, Guyatt G, Wyer P, Naylor C, Stiell I, Richardson W: Users’ guides to the medical literature: XXII: how to use articles about clinical decision rules. JAMA. 2000, 284: 79-84. 10.1001/jama.284.1.79.CrossRefPubMed McGinn T, Guyatt G, Wyer P, Naylor C, Stiell I, Richardson W: Users’ guides to the medical literature: XXII: how to use articles about clinical decision rules. JAMA. 2000, 284: 79-84. 10.1001/jama.284.1.79.CrossRefPubMed
7.
go back to reference Keogh C, Wallace E, O’Brien K, Murphy P, Teljeur C, McGrath B, Smith SM, Doherty N, Dimitrov BD, Fahey T: Optimized retrieval of primary care clinical prediction rules from MEDLINE to establish a Web-based register. J Clin Epidemiol. 2011, 64 (8): 848-860. 10.1016/j.jclinepi.2010.11.011.CrossRefPubMed Keogh C, Wallace E, O’Brien K, Murphy P, Teljeur C, McGrath B, Smith SM, Doherty N, Dimitrov BD, Fahey T: Optimized retrieval of primary care clinical prediction rules from MEDLINE to establish a Web-based register. J Clin Epidemiol. 2011, 64 (8): 848-860. 10.1016/j.jclinepi.2010.11.011.CrossRefPubMed
8.
go back to reference McCowan C, Donnan P, Dewar J, Thompson A, Fahey T: Identifying suspected breast cancer: development and validation of a clinical prediction rule. Br J Gen Pract. 2011, 61 (586): e205-e214. 10.3399/bjgp11X572391.CrossRefPubMedPubMedCentral McCowan C, Donnan P, Dewar J, Thompson A, Fahey T: Identifying suspected breast cancer: development and validation of a clinical prediction rule. Br J Gen Pract. 2011, 61 (586): e205-e214. 10.3399/bjgp11X572391.CrossRefPubMedPubMedCentral
9.
go back to reference von Elm E, Altman D, Egger M, Pocock S, Gøtzsche P, Vandenbroucke J, STROBE-Initiative: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008, 64 (4): 344-349.CrossRef von Elm E, Altman D, Egger M, Pocock S, Gøtzsche P, Vandenbroucke J, STROBE-Initiative: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008, 64 (4): 344-349.CrossRef
10.
go back to reference Sullivan L, Massaro J, D’Agostino RS: Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med. 2004, 23 (10): 1631-1660. 10.1002/sim.1742.CrossRefPubMed Sullivan L, Massaro J, D’Agostino RS: Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med. 2004, 23 (10): 1631-1660. 10.1002/sim.1742.CrossRefPubMed
11.
go back to reference Hosmer D, Hosmer T, Le Cessie S, Lemeshow S: A comparison of goodness-of-fit tests for the logistic regression model. Stat Med. 1997, 16 (9): 965-980. 10.1002/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O.CrossRefPubMed Hosmer D, Hosmer T, Le Cessie S, Lemeshow S: A comparison of goodness-of-fit tests for the logistic regression model. Stat Med. 1997, 16 (9): 965-980. 10.1002/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O.CrossRefPubMed
12.
go back to reference Swets J: Measuring the accuracy of diagnostic systems. Science. 1998, 240 (4857): 1285-1293.CrossRef Swets J: Measuring the accuracy of diagnostic systems. Science. 1998, 240 (4857): 1285-1293.CrossRef
13.
go back to reference Okazaki A, Hirata K, Okazaki M, Svane G, Azavedo E: Nipple discharge disorders: current diagnostic management and the role of fiber-ductoscopy. Eur Radiol. 1999, 9 (4): 583-590. 10.1007/s003300050715.CrossRefPubMed Okazaki A, Hirata K, Okazaki M, Svane G, Azavedo E: Nipple discharge disorders: current diagnostic management and the role of fiber-ductoscopy. Eur Radiol. 1999, 9 (4): 583-590. 10.1007/s003300050715.CrossRefPubMed
14.
go back to reference Reeves M, Osuch J, Pathak D: Development of a clinical decision rule for triage of women with palpable breast masses. J Clin Epidemiol. 2003, 56 (7): 636-645. 10.1016/S0895-4356(03)00123-9.CrossRefPubMed Reeves M, Osuch J, Pathak D: Development of a clinical decision rule for triage of women with palpable breast masses. J Clin Epidemiol. 2003, 56 (7): 636-645. 10.1016/S0895-4356(03)00123-9.CrossRefPubMed
15.
go back to reference Campbell C, Durning P, Cheema I, Naisby G: A simple tool for rapid access to a symptomatic breast clinic. Eur J Surg Oncol. 2004, 30 (3): 248-251. 10.1016/j.ejso.2003.11.010.CrossRefPubMed Campbell C, Durning P, Cheema I, Naisby G: A simple tool for rapid access to a symptomatic breast clinic. Eur J Surg Oncol. 2004, 30 (3): 248-251. 10.1016/j.ejso.2003.11.010.CrossRefPubMed
16.
go back to reference Hippisley-Cox J, Coupland C: Symptoms and risk factors to identify women with suspected breast cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract. 2013, 63 (606): e11-e21.CrossRefPubMed Hippisley-Cox J, Coupland C: Symptoms and risk factors to identify women with suspected breast cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract. 2013, 63 (606): e11-e21.CrossRefPubMed
17.
go back to reference Barton M, Elmore J, Fletcher S: Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med. 1999, 130 (8): 651-657. 10.7326/0003-4819-130-8-199904200-00005.CrossRefPubMed Barton M, Elmore J, Fletcher S: Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med. 1999, 130 (8): 651-657. 10.7326/0003-4819-130-8-199904200-00005.CrossRefPubMed
18.
go back to reference Khawaja A, Allan S: Has the breast cancer ‘two week wait’ guarantee for assessment made any difference?. Eur J Surg Oncol. 2000, 26 (6): 536-539. 10.1053/ejso.2000.0942.CrossRefPubMed Khawaja A, Allan S: Has the breast cancer ‘two week wait’ guarantee for assessment made any difference?. Eur J Surg Oncol. 2000, 26 (6): 536-539. 10.1053/ejso.2000.0942.CrossRefPubMed
19.
go back to reference Onstad M, Stuckey A: Benign breast disorders. Obstet Gynecol Clin North Am. 2013, 40 (3): 459-473. 10.1016/j.ogc.2013.05.004.CrossRefPubMed Onstad M, Stuckey A: Benign breast disorders. Obstet Gynecol Clin North Am. 2013, 40 (3): 459-473. 10.1016/j.ogc.2013.05.004.CrossRefPubMed
20.
go back to reference Eberl M, Phillips R, Lamberts H, Okkes I, Mahoney M: Characterizing breast symptoms in family practice. Ann Fam Med. 2008, 6 (6): 528-533. 10.1370/afm.905.CrossRefPubMedPubMedCentral Eberl M, Phillips R, Lamberts H, Okkes I, Mahoney M: Characterizing breast symptoms in family practice. Ann Fam Med. 2008, 6 (6): 528-533. 10.1370/afm.905.CrossRefPubMedPubMedCentral
21.
go back to reference Khan S, Apkarian A: The characteristics of cyclical and non-cyclical mastalgia: a prospective study using a modified McGill Pain Questionnaire. Breast Cancer Res Treat. 2002, 75 (2): 147-157. 10.1023/A:1019685829799.CrossRefPubMed Khan S, Apkarian A: The characteristics of cyclical and non-cyclical mastalgia: a prospective study using a modified McGill Pain Questionnaire. Breast Cancer Res Treat. 2002, 75 (2): 147-157. 10.1023/A:1019685829799.CrossRefPubMed
22.
go back to reference Davids S, Schapira M, McAuliffe T, Nattinger A: Predictors of pessimistic breast cancer risk perceptions in a primary care population. J Gen Intern Med. 2004, 19 (4): 310-315. 10.1111/j.1525-1497.2004.20801.x.CrossRefPubMedPubMedCentral Davids S, Schapira M, McAuliffe T, Nattinger A: Predictors of pessimistic breast cancer risk perceptions in a primary care population. J Gen Intern Med. 2004, 19 (4): 310-315. 10.1111/j.1525-1497.2004.20801.x.CrossRefPubMedPubMedCentral
23.
go back to reference Alexander N, Ross J, Sumner W, Nease R, Littenberg B: The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med. 1996, 11 (2): 92-97. 10.1007/BF02599584.CrossRefPubMed Alexander N, Ross J, Sumner W, Nease R, Littenberg B: The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med. 1996, 11 (2): 92-97. 10.1007/BF02599584.CrossRefPubMed
24.
go back to reference Newton P, Hannay D, Laver R: The presentation and management of female breast symptoms in general practice in Sheffield. Fam Pract. 1999, 16 (4): 60-65.CrossRef Newton P, Hannay D, Laver R: The presentation and management of female breast symptoms in general practice in Sheffield. Fam Pract. 1999, 16 (4): 60-65.CrossRef
25.
go back to reference Colditz G, Kaphingst K, Hankinson S, Rosner B: Family history and risk of breast cancer: nurses’ health study. Breast Cancer Res Treat. 2012, 133 (3): 1097-1104. 10.1007/s10549-012-1985-9.CrossRefPubMedPubMedCentral Colditz G, Kaphingst K, Hankinson S, Rosner B: Family history and risk of breast cancer: nurses’ health study. Breast Cancer Res Treat. 2012, 133 (3): 1097-1104. 10.1007/s10549-012-1985-9.CrossRefPubMedPubMedCentral
26.
go back to reference Sauven P: Impact of the “2 week wait” on referrals to breast units in the UK. Breast. 2002, 11 (3): 262-264. 10.1054/brst.2001.0390.CrossRefPubMed Sauven P: Impact of the “2 week wait” on referrals to breast units in the UK. Breast. 2002, 11 (3): 262-264. 10.1054/brst.2001.0390.CrossRefPubMed
27.
go back to reference Potter S, Govindarajulu S, Shere M, Braddon F, Curran G, Greenwood R, Sahu A, Cawthorn S: Referrral patterns, cancer diagnoses and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study. BMJ. 2007, 335 (7614): 288-10.1136/bmj.39258.688553.55.CrossRefPubMedPubMedCentral Potter S, Govindarajulu S, Shere M, Braddon F, Curran G, Greenwood R, Sahu A, Cawthorn S: Referrral patterns, cancer diagnoses and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study. BMJ. 2007, 335 (7614): 288-10.1136/bmj.39258.688553.55.CrossRefPubMedPubMedCentral
28.
go back to reference Hamilton W: The CAPER studies: five case–control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009, 101 (Suppl 2): S80-S86.CrossRefPubMedPubMedCentral Hamilton W: The CAPER studies: five case–control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009, 101 (Suppl 2): S80-S86.CrossRefPubMedPubMedCentral
Metadata
Title
Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study
Authors
Rose Galvin
Doireann Joyce
Eithne Downey
Fiona Boland
Tom Fahey
Arnold K Hill
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-743

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine